The effects of RanGap1 on ROS and mitochondrial function imply that RanGap1 might become a novel target in the preventive and treatment on tumors and diseases, especially in breast cancer and mitochondrial diseases. The gene discussed is RANGAP1; the disease is inborn mitochondrial metabolism disorder.